Integrated Business Objects and IBM Solution Helps Healthcare Organizations to Better Leverage Patient Information to Strengthen Research and Decision Making
SAN DIEGO--(BUSINESS WIRE)--Feb. 13, 2006--Business Objects (Nasdaq:BOBJ) (Euronext Paris ISIN code: FR0004026250 - BOB), the world's leading provider of business intelligence (BI) solutions, today announced a healthcare and life sciences offering with IBM. Together, Business Objects and IBM offer a simplified way for organizations in healthcare and life-science industry segments (HCLS) to make sense of the growing amount of data used in research and clinical environments.
As part of the integrated offering, IBM's Clinical Genomics (CG) solution is now enhanced with business intelligence capabilities from Business Objects. This solution enables HCLS companies to quickly synthesize and visualize genomic and pharmacogenomic information used in critical tasks, such as the development of new customized drug therapies and the improvement of patient diagnosis and treatment.
Additional uses for the solution includes helping HCLS organizations identify a list of potential candidates that fit a profile for a research study, as well as predicting "at risk" patients based on their similarity to a patient cluster -- ultimately improving the effectiveness of diagnosis and treatment. Eventually, simplification of data may also enable researchers to be able to customize drug therapies for specific patient populations.
"Most genomics data is buried in complex data mining models that very few people can access and understand," said Robb Eklund, vice president of industry solutions marketing at Business Objects. "The IBM CG solution can bring this data together, from wherever it may reside, with Business Objects providing rich visualization and simplified analysis for doctors and researchers who need it. Although these doctors need a degree in medicine, they won't need a degree in mathematics to use and understand the data."
"By helping businesses organize information, unlock its fundamental value, and weave it into core processes, the solution enables organizations to become on-demand businesses," says Mike Svinte, vice president of IBM's Information-Based Medicine Business Unit. "By making large amounts of phenotypic and genotypic information easily available, researchers and healthcare organization are able to understand underlying mechanisms of disease. Thus, the solution has the potential to revolutionize the way treatments are developed and care is delivered."
For more information on Business Objects solutions for the healthcare and pharmaceuticals industries, please visit http://www.businessobjects.com/solutions/.
About IBM Healthcare and Life Sciences
IBM Healthcare and Life Sciences brings together IBM resources, including information technology, deep industry insights, and research expertise, to help clients develop and deliver safer, more affordable and more effective diagnostics, drugs and medical care. For additional information, visit: www.ibm.com.
Business Objects has been a pioneer in business intelligence (BI) since the dawn of the category. Today, as the world's leading BI software company, Business Objects transforms the way the world works through intelligent information. The company helps illuminate understanding and decision-making at more than 46,000 organizations around the globe. Through a combination of innovative technology, global consulting and education services, and the industry's strongest and most diverse partner network, Business Objects enables companies of all sizes to make transformative business decisions based on intelligent, accurate, and timely information.
Business Objects has dual headquarters in San Jose, Calif., and Paris, France. The company's stock is traded on both the Nasdaq (BOBJ) and Euronext Paris (ISIN: FR0004026250 - BOB) stock exchanges. More information about Business Objects can be found at www.businessobjects.com.
Business Objects and the Business Objects logo, BusinessObjects and Crystal Reports are trademarks or registered trademarks of Business Objects in the United States and/or other countries. All other names mentioned herein may be trademarks of their respective owners.
# # #
The Business Objects logo, BusinessObjects, Crystal Reports, Intelligent Question, and Xcelsius are trademarks or registered trademarks of Business Objects in the United States and/or other countries. All other names mentioned herein may be trademarks of their respective owners.